Stay updated on Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial
Sign up to get notified when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.

Latest updates to the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA minor site revision update was added (Revision: v3.4.2) and the prior government funding/status notice was removed (Revision: v3.4.1), with no impact on study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide funding/status notice was added and a PubMed publication reference related to the study was included. These updates do not change the core study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedGlossary content is now displayed on the page. Metadata labels were updated to show Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 added and v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedA unified 'Locations' section lists sites in California, New Jersey, and New York; prior 'California Locations', 'New Jersey Locations', and 'New York Locations' sections were removed, and the revision version updated from v3.3.2 to v3.3.3.SummaryDifference0.4%

- Check92 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.